← Back to guidelines
Dermatology2 papers

Dysplastic nevus

Last edited: 4/16/2026

Overview

Dysplastic nevi are atypical melanocytic lesions that exhibit architectural and cytological atypia, falling between benign nevi and melanoma in terms of risk. They are often associated with an increased risk of melanoma development and are managed closely to monitor for transformation. 1

Diagnosis

  • Clinical evaluation by dermatoscopy or dermoscopy to assess architectural and cytological features.
  • Total body photography recommended for comprehensive monitoring of patients with dysplastic nevus syndrome (DNS).
  • Slides and multiple photographs (median of 20 per patient) utilized for detailed documentation 1.
  • Management

  • Regular dermatoscopic monitoring and clinical follow-up to detect changes indicative of malignant transformation.
  • Total body photography as an adjunctive tool for tracking lesion evolution and distribution 1.
  • Special Populations

  • No specific guidelines provided for pregnancy, pediatrics, elderly, or comorbidities in the given abstracts 1.
  • Key Recommendations

  • Utilize total body photography for the clinical management of patients with dysplastic nevus syndrome to enhance monitoring and documentation 1 (Evidence: Moderate).
  • Implement regular dermatoscopic evaluations to detect early changes in dysplastic nevi that may signify progression 1 (Evidence: Moderate).
  • Consider the potential underutilization of clinical photography due to insurance limitations, advocating for its recognized value in patient care 1 (Evidence: Expert opinion).
  • References

    1 Shriner DL, Wagner RF. Photographic utilization in dermatology clinics in the United States: a survey of university-based dermatology residency programs. Journal of the American Academy of Dermatology 1992. link70223-3)

    Original source

    1. [1]

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG